OTCPK:GIDY.L

Stock Analysis Report

Executive Summary

GI Dynamics, Inc., a medical device company, engages in the development, manufacture, and marketing of medical devices for non-surgical approaches to treat type 2 diabetes and obesity.

Snowflake

Fundamentals

Worrying balance sheet with weak fundamentals.

Risks

  • GI Dynamics has significant price volatility in the past 3 months.
  • GI Dynamics is not covered by any analysts.

Similar Companies

Share Price & News

How has GI Dynamics's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-26.7%

GIDY.L

1.1%

US Medical Equipment

-0.6%

US Market


1 Year Return

27.9%

GIDY.L

9.9%

US Medical Equipment

0.6%

US Market

GIDY.L outperformed the Medical Equipment industry which returned 9.5% over the past year.

GIDY.L outperformed the Market in United States of America which returned 1.1% over the past year.


Share holder returns

GIDY.LIndustryMarket
7 Day-26.7%1.1%-0.6%
30 Day0%0.6%2.2%
90 Dayn/a2.9%1.1%
1 Year27.9%27.9%10.8%9.9%2.9%0.6%
3 Year15.8%15.8%70.1%64.9%44.6%35.2%
5 Year-94.3%-94.3%138.9%111.8%61.9%44.2%

Price Volatility Vs. Market

How volatile is GI Dynamics's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is GI Dynamics undervalued based on future cash flows and its price relative to the stock market?


In this section, we usually try to help investors determine whether GI Dynamics is trading at an attractive price based on the cash flow it is expected to produce in the future. But as GI Dynamics has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

Future Growth

How is GI Dynamics expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

22.5%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as GI Dynamics has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of GIDY.L’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access GI Dynamics's filings and announcements here.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has GI Dynamics performed over the past 5 years?

38.0%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

GI Dynamics does not make a profit even though their year on year earnings growth rate was positive over the past 5 years.

Unable to compare GI Dynamics's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare GI Dynamics's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if GI Dynamics has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) due to its liabilities exceeding its assets.


Return on Assets

It is difficult to establish if GI Dynamics has efficiently used its assets last year compared to the US Medical Equipment industry average (Return on Assets) as it is loss-making.


Return on Capital Employed

It is difficult to establish if GI Dynamics improved its use of capital last year versus 3 years ago (Return on Capital Employed) due to its liabilities exceeding its assets.


Next Steps

Financial Health

How is GI Dynamics's financial position?


Financial Position Analysis

GI Dynamics's short term (1 year) commitments are greater than its holdings of cash and other short term assets.

GI Dynamics's cash and other short term assets cover its long term commitments.


Debt to Equity History and Analysis

GI Dynamics has negative shareholder equity (liabilities exceed assets), this is a more serious situation compared with a high debt level.

Irrelevant to check if GI Dynamics's debt level has increased considering it has negative shareholder equity.


Balance Sheet

Low level of unsold assets.

GI Dynamics has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

GI Dynamics has less than a year of cash runway based on current free cash flow.

GI Dynamics has less than a year of cash runway if free cash flow continues to reduce at historical rates of -27.6% each year.


Next Steps

Dividend

What is GI Dynamics's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate GI Dynamics's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate GI Dynamics's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as GI Dynamics has not reported any payouts.

Unable to verify if GI Dynamics's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as GI Dynamics has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of GI Dynamics's salary, the management and board of directors tenure and is there insider trading?

2.5yrs

Average board tenure


CEO

Scott Schorer (51yo)

3.5yrs

Tenure

US$866,000

Compensation

Mr. Scott W. Schorer has been the Chief Executive Officer and President of GI Dynamics, Inc. since March 2016. Mr. Schorer served as the Chief Executive Officer of PlasmaTech Biopharmaceuticals, Inc. since ...


CEO Compensation Analysis

Scott's remuneration is higher than average for companies of similar size in United States of America.

Scott's compensation has increased whilst company is loss making.


Board Age and Tenure

2.5yrs

Average Tenure

61.5yo

Average Age

The average tenure for the GI Dynamics board of directors is less than 3 years, this suggests a new board.


Insider Trading

No 3 month open market individual insider trading information.


Recent Insider Transactions

BuyUS$2,68704 Sep 19
Crystal Amber Advisers (UK) LLP
EntityCompany
Shares120,700
Max PriceUS$0.022
BuyUS$36,73225 Aug 19
Crystal Amber Advisers (UK) LLP
EntityCompany
Shares1,606,116
Max PriceUS$0.024
BuyUS$36,63707 Jul 19
Crystal Amber Advisers (UK) LLP
EntityCompany
Shares1,919,741
Max PriceUS$0.021
BuyUS$2,369,80912 Jun 19
Crystal Amber Advisers (UK) LLP
EntityCompany
Shares169,123,053
Max PriceUS$0.014

Ownership Breakdown


Management Team

  • Scott Schorer (51yo)

    CEO & President

    • Tenure: 3.5yrs
    • Compensation: US$866.00k
  • Keith Gersin

    Chief Medical Advisor

    • Tenure: 0yrs
  • Manoel Neto

    Scientific Advisor of Gastroenterology & Member of Scientific Advisory Board

    • Tenure: 2.5yrs
  • Charles Carter (52yo)

    CFO, Treasurer & Secretary

    • Tenure: 0.8yrs
    • Compensation: US$29.37k

Board Members

  • Tim Barberich (71yo)

    Non Executive Director

    • Tenure: 8.3yrs
    • Compensation: US$63.00k
  • Juliet Thompson (53yo)

    Non Executive Director

    • Tenure: 2.1yrs
    • Compensation: US$65.00k
  • Oern Stuge (65yo)

    Non-Executive Director

    • Tenure: 2.7yrs
    • Compensation: US$56.00k
  • Dan Moore (58yo)

    Non-Executive Chairman

    • Tenure: 3.3yrs
    • Compensation: US$76.00k
  • David Cummings

    Member of Scientific Advisory Board

    • Tenure: 2.5yrs
  • Francesco Rubino

    Member of Scientific Advisory Board

    • Tenure: 2.3yrs
  • Ricardo Cohen

    Member of Scientific Advisory Board

    • Tenure: 2.3yrs
  • Jan Greve

    Member of Scientific Advisory Board

    • Tenure: 2.5yrs
  • Manoel Neto

    Scientific Advisor of Gastroenterology & Member of Scientific Advisory Board

    • Tenure: 2.5yrs
  • Carel le Roux

    Member of Scientific Advisory Board

    • Tenure: 2.5yrs

Company Information

GI Dynamics, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: GI Dynamics, Inc.
  • Ticker: GIDY.L
  • Exchange: OTCPK
  • Founded: 2003
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: AU$51.544m
  • Listing Market Cap: AU$34.898m
  • Shares outstanding: 1.56b
  • Website: https://www.gidynamics.com

Number of Employees


Location

  • GI Dynamics, Inc.
  • PO Box 51915
  • Boston
  • Massachusetts
  • 2205
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
GIDASX (Australian Securities Exchange)YesSHS CHESS DEPAUAUDSep 2011
GIDY.LOTCPK (Pink Sheets LLC)YesSHS CHESS DEPUSUSDSep 2011
2GDDB (Deutsche Boerse AG)YesSHS CHESS DEPDEEURSep 2011
GIDCHIA (Chi-X Australia)YesSHS CHESS DEPAUAUDSep 2011
2GDBST (Boerse-Stuttgart)YesSHS CHESS DEPDEEURSep 2011

Biography

GI Dynamics, Inc., a medical device company, engages in the development, manufacture, and marketing of medical devices for non-surgical approaches to treat type 2 diabetes and obesity. The company offers E ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/21 00:06
End of Day Share Price2019/09/20 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.